Herring-Nicholas Ashley, Fisher-Huynh Stephanie, Josephs Eric A
Department of Nanoscience; The Joint School of Nanoscience and Nanoengineering; UNC Greensboro; Greensboro, North Carolina, USA.
Department of Biology; College of Arts and Sciences; UNC Greensboro; Greensboro, North Carolina, USA.
bioRxiv. 2025 May 10:2025.05.06.652491. doi: 10.1101/2025.05.06.652491.
RNA-guided CRISPR nuclease Cas9 cannot reliably differentiate between single nucleotide variations (SNVs) of targeted DNA sequences determined by their guide RNA (gRNA): they typically exhibit similar nuclease activities at any of those variations, unless the variation occurs with specific sequence contexts known as protospacer adjacent motifs (PAMs). Our approach, "TOP-SECRETS," generates gRNA variants that allow Cas9 ribonucleoproteins (RNPs) to reliably discriminate between healthy and disease-associated SNVs outside of PAMs.
RNA引导的CRISPR核酸酶Cas9无法可靠地区分由其引导RNA(gRNA)确定的靶向DNA序列的单核苷酸变异(SNV):在这些变异中的任何一个处,它们通常表现出相似的核酸酶活性,除非该变异发生在被称为原间隔相邻基序(PAM)的特定序列背景中。我们的方法“TOP-SECRETS”生成gRNA变体,使Cas9核糖核蛋白(RNP)能够可靠地区分PAM之外的健康和疾病相关SNV。